title: Systematic drugs as a risk factor for periodontal disease initiation and progression.
abstract: There are many systemic drugs taken by patients that affect their periodontal statuses. Dentists are in a position to diagnose and manage these problems and, when appropriate, discuss possible alternative drug therapies with physician colleagues.
authors.affiliation: Department of Periodontics, Baylor College of Dentistry, Dallas, Texas, USA.
authors.forename: T D
authors.initials: TD
authors.lastname: Rees
authors.forename: R A
authors.initials: RA
authors.lastname: Levine
mesh_terms: D002121:Calcium Channel Blockers / Q000009:adverse effects*; D016572:Cyclosporine / Q000009:adverse effects*; D005260:Female; D005351:Fibromatosis, Gingival / Q000139:chemically induced*; D005885:Gingival Hyperplasia / Q000139:chemically induced*; D012739:Gonadal Steroid Hormones / Q000009:adverse effects; D006801:Humans; D008297:Male; D009543:Nifedipine / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects*
chemical_list: D002121:Calcium Channel Blockers; D012739:Gonadal Steroid Hormones; D010672:Phenytoin; D016572:Cyclosporine; D009543:Nifedipine